Optimized procedure of real-time systemic leakage monitoring during isolated limb perfusion using a hand held gamma probe and 99mtc-hsa

Nuclear Medicine Communications

Volumn 25, Issue 1, 2004, Pages 61-66

  Casara, D ^a   Rubello, D ^a   Pilati, P ^a   Scalerta, R ^a   Foletto, M ^a   Rossi, C R ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

99mTc human soluble serum albumin (HSA); Hand held gamma probe; Isolated limb perfusion; Leakage monitoring; Tumour necrosis factor alpha (TNF)

Indexed keywords

SERUM ALBUMIN I 131; SERUM ALBUMIN TC 99M; TECHNETIUM 99M;

ARTICLE; BIOLOGICAL MONITORING; BODY WEIGHT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SIMULATION; DOSE CALCULATION; HUMAN; INJECTION; INTERMETHOD COMPARISON; ISOTOPE LABELING; LIMB PERFUSION; MECHANICAL PROBE; RADIOACTIVE CONTAMINATION; RADIOACTIVITY; SKIN;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DRUG THERAPY, COMPUTER-ASSISTED; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; EXTREMITIES; GAMMA CAMERAS; HUMANS; MELANOMA; RADIOISOTOPE DILUTION TECHNIQUE; RADIOPHARMACEUTICALS; SARCOMA; SKIN NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0842334075     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200401000-00009     Document Type: Article

References (20)

1. Creech OJ, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Am Surg 1958; 148: 616-632.
2. Lejeune FJ, Lienard D, El Douaihy M, Vadoud Seyedi J, Ewalenko P. Results of 206 isolated limb perfusion for malignant melanoma. Eur J Surg Oncol 1989; 15: 510-519.
3. Vrouenraets BC, Nieweg OE, Kroon BB. Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg 1996; 83: 1329-1338.
4. Liènard D, Eggermont AMM, Schraffordt Koop H, et al. Isolated perfusion of the limb with high dose tumor necrosis factor-alfa and interferon-gamma and melfalan for melanoma stage III: results of a multi-center pilot study. Melanoma Res 1994; 4: 21-26.
5. Eggermont AMM, Schraffordt Koop H, Liènard D, et al. Isolated limb perfusion with high dose tumor necrosis factor-alfa in combination with interferon-gamma and melfalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol 1996; 14: 2653-2665.
6. Rossi CR, Foletto M, Di Filippo F, et al. Soft tissue limb sarcomas. Italian clinical trials with hyperthermic antiblastic perfusion. Cancer 1999; 86: 1742-1749.
7. Eggimann P, Chiolero R, Chassot PG, Lienard D, Gerain J, Lejeune FJ. Systemic and hemodynamic effects of recombinant tumor necrosis factor alfa in isolation perfusion of the limbs. Chest 1995; 107: 1074-1082.
8. Stehlin JS, Clark RL, Dewey W. Continuous monitoring of leakage during regional perfusion. Arch Surg 1961; 83: 165-171.
9. Barker WC, Andrich MP, Alexander HR, Fraker DL. Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs. Eur J Nucl Med 1995; 22: 1242-1248.
10. Van Ginkel RJ, Limburg PC, Piers DA, et al. Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-alfa and melphalan. Ann Surg Oncol 2002; 9: 355-363.
11. Rossi CR, Vecchiato A, Foletto M, et al. Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas. Cancer 1994; 73: 2140-2146.
12. Eggermont AM, Schraffordt Koops H, Klausner JM. Limb salvage by isolated limb perfusion (ILP) with TNF and melphalan in patients with locally advanced soft tissue sarcomas: outcome of 270 ILPs in 246 patients. Annu Proc Am Soc Clin Oncol 1999; 2067 (abstract).
13. Lejeune FJ, Ghanem GE, Lienard D, Ewalenko P. An accurate method for cytostatic dosimetry in isolation perfusion based on limb vascular volume determination. Antibiot Chemother 1988; 40: 63-76.
14. Alexander C, Omlor G, Berberich R, Gross G, Feifel G. Rapid measurement during of blood leakage during regional chemotherapy. Eur J Nucl Med 1993; 20: 187-191.
15. Sandrock D, Horst F, Gatzeimeier W, et al. Leakage measurement during selective limb perfusion using a gamma probe. Eur J Nucl Med 1996; 23: 534-538.
16. Sardi A, Minton JP, Mojzisic C, et al. The use of hand-held gamma detector improves the safety of isolated limb perfusion. J Surg Oncol 1989; 41: 172-176.
17. Rossi CR, Scagnet B, Vecchiati A, et al. Sentinel node biopsy and ultrasound scanning in cutaneous melanoma. Clinical and technical considerations. Eur J Cancer 2000; 36: 895-900.
18. Zavagno G, Busolin R, Bozza F, et al. Sentinel node biopsy in breast cancer. The Breast 2000; 9: 139-143.
19. 4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 2001; 28: 1351-1359.
20. Gerain J, Lienard D, Ewalenko P, Lejeune FJ. High serum levels of TNF-alfa after its administration for isolation perfusion of the limbs. Cytokine 1992; 4: 585-591.